Anna Scomparin
Impact in
- Biomaterials top 2%
- Nanoparticle-Based Drug Delivery
- Pharmaceutical Science top 2%
- Advanced Drug Delivery Systems
Papers in
- Biomaterials 13
- Nanoparticle-Based Drug Delivery 12
- Oncology 14
- Co-authors
- Ronit Satchi‐Fainaro (34 shared papers)Anat Eldar‐Boock (7 shared papers)Galia Tiram (11 shared papers)Dina Polyak (8 shared papers)Paula Ofek (6 shared papers)Doron Shabat (4 shared papers)Stefano Salmaso (9 shared papers)Paolo Caliceti (9 shared papers)
- Journals
- Journal of Controlled Release (8 papers)Bioconjugate Chemistry (4 papers)Pharmaceutics (2 papers)Advanced Drug Delivery Reviews (2 papers)International Journal of Pharmaceutics (2 papers)
- Partner nations
- IsraelItalyUnited States
In The Last Decade
Anna Scomparin
51 papers receiving 2.1k citations
Peers
Comparison fields: 5 of 115
- Biomaterials 660
- Pharmaceutical Science 180
- Immunology 317
- Biomedical Engineering 687
- Molecular Medicine 72
Countries citing papers authored by Anna Scomparin
This map shows the geographic impact of Anna Scomparin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anna Scomparin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anna Scomparin more than expected).
Fields of papers citing papers by Anna Scomparin
This network shows the impact of papers produced by Anna Scomparin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anna Scomparin. The network helps show where Anna Scomparin may publish in the future.
Co-authors
The 25 scholars most cited alongside Anna Scomparin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 52 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2011 | 277 | |
| 2 | 2019 | 202 | |
| 3 | 2018 | 118 | |
| 4 | 2013 | 101 | |
| 5 | 2016 | 100 | |
| 6 | 2017 | 90 | |
| 7 | 2017 | 84 | |
| 8 | 2011 | 76 | |
| 9 | 2019 | 75 | |
| 10 | 2019 | 74 | |
| 11 | 2015 | 72 | |
| 12 | 2018 | 63 | |
| 13 | 2019 | 57 | |
| 14 | 2013 | 56 | |
| 15 | 2021 | 53 | |
| 16 | 2020 | 50 | |
| 17 | 2019 | 43 | |
| 18 | 2015 | 43 | |
| 19 | 2015 | 39 | |
| 20 | 2023 | 38 |
About Anna Scomparin
Anna Scomparin is a scholar working on Biomaterials, Oncology, Molecular Biology, Immunology and Pharmaceutical Science, having authored 52 papers that have together received 2.1k indexed citations. Recurring topics across this work include RNA Interference and Gene Delivery (21 papers), Advanced biosensing and bioanalysis techniques (17 papers), Nanoparticle-Based Drug Delivery (12 papers), Nanoplatforms for cancer theranostics (10 papers), Immunotherapy and Immune Responses (8 papers), Advanced Drug Delivery Systems (5 papers), Graphene and Nanomaterials Applications (4 papers) and DNA and Nucleic Acid Chemistry (4 papers). The work is most often cited by research in Biomaterials (660 citations), Pharmaceutical Science (180 citations), Immunology (317 citations), Biomedical Engineering (687 citations) and Molecular Medicine (72 citations). Anna Scomparin has collaborated with scholars based in Israel, Italy and United States. Frequent co-authors include Ronit Satchi‐Fainaro, Anat Eldar‐Boock, Galia Tiram, Dina Polyak, Paula Ofek, Doron Shabat, Stefano Salmaso, Paolo Caliceti, Adva Krivitsky and Shiran Ferber. Their work appears in journals such as Journal of Controlled Release, Bioconjugate Chemistry, Pharmaceutics, Advanced Drug Delivery Reviews and International Journal of Pharmaceutics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.